JP2023526057A5 - - Google Patents
Info
- Publication number
- JP2023526057A5 JP2023526057A5 JP2022568828A JP2022568828A JP2023526057A5 JP 2023526057 A5 JP2023526057 A5 JP 2023526057A5 JP 2022568828 A JP2022568828 A JP 2022568828A JP 2022568828 A JP2022568828 A JP 2022568828A JP 2023526057 A5 JP2023526057 A5 JP 2023526057A5
- Authority
- JP
- Japan
- Prior art keywords
- crrna
- tracrrna
- group
- modification
- guide rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063023313P | 2020-05-12 | 2020-05-12 | |
| US63/023,313 | 2020-05-12 | ||
| PCT/US2021/032038 WO2021231606A2 (en) | 2020-05-12 | 2021-05-12 | Modified guide rnas for crispr genome editing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526057A JP2023526057A (ja) | 2023-06-20 |
| JP2023526057A5 true JP2023526057A5 (https=) | 2024-05-22 |
Family
ID=78524997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568828A Pending JP2023526057A (ja) | 2020-05-12 | 2021-05-12 | Ｃｒｉｓｐｒゲノム編集のための修飾されたガイドｒｎａ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210388348A1 (https=) |
| EP (1) | EP4150091A4 (https=) |
| JP (1) | JP2023526057A (https=) |
| CN (1) | CN115956120A (https=) |
| AU (1) | AU2021271004A1 (https=) |
| CA (1) | CA3177463A1 (https=) |
| WO (1) | WO2021231606A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240034661A (ko) * | 2022-09-06 | 2024-03-14 | 주식회사 툴젠 | 캄필로박터 제주니 유래 Cas9의 가이드 RNA 구조변화를 통한 유전자교정 향상 시스템 |
| AU2024270764A1 (en) | 2023-05-15 | 2025-12-04 | Nchroma Bio, Inc. | Compositions and methods for epigenetic regulation of hbv gene expression |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2745769T3 (es) * | 2014-03-10 | 2020-03-03 | Editas Medicine Inc | Procedimientos y composiciones relacionados con CRISPR/CAS para tratar la amaurosis congénita de Leber 10 (LCA10) |
| CA2970683A1 (en) * | 2014-12-18 | 2016-06-23 | Integrated Dna Technologies, Inc. | Crispr-based compositions and methods of use |
| US9650617B2 (en) * | 2015-01-28 | 2017-05-16 | Pioneer Hi-Bred International. Inc. | CRISPR hybrid DNA/RNA polynucleotides and methods of use |
| JP2018515142A (ja) * | 2015-05-15 | 2018-06-14 | ダーマコン，インコーポレイテッド． | Ｃａｓ９介在遺伝子編集用の合成シングルガイドｒｎａ |
| WO2017004261A1 (en) * | 2015-06-29 | 2017-01-05 | Ionis Pharmaceuticals, Inc. | Modified crispr rna and modified single crispr rna and uses thereof |
| EP3356533A1 (en) * | 2015-09-28 | 2018-08-08 | North Carolina State University | Methods and compositions for sequence specific antimicrobials |
| CA2947904A1 (en) * | 2015-11-12 | 2017-05-12 | Pfizer Inc. | Tissue-specific genome engineering using crispr-cas9 |
| CA3034931A1 (en) * | 2016-09-23 | 2018-03-29 | Board Of Trustees Of Southern Illinois University | Tuning crispr/cas9 activity with chemically modified nucleotide substitutions |
| SG10202106058WA (en) * | 2016-12-08 | 2021-07-29 | Intellia Therapeutics Inc | Modified guide rnas |
| US20190032131A1 (en) * | 2016-12-12 | 2019-01-31 | Integrated Dna Technologies, Inc. | Genome editing detection |
| US20210130817A1 (en) * | 2017-07-14 | 2021-05-06 | Cure Genetics Co., Ltd. | Gene Editing System and Gene Editing Method |
| US20210363518A1 (en) * | 2018-03-19 | 2021-11-25 | University Of Massachusetts | Modified guide rnas for crispr genome editing |
| KR20210045360A (ko) * | 2018-05-16 | 2021-04-26 | 신테고 코포레이션 | 가이드 rna 설계 및 사용을 위한 방법 및 시스템 |
| AU2019282824C1 (en) * | 2018-06-08 | 2026-04-23 | Intellia Therapeutics, Inc. | Modified guide RNAS for gene editing |
-
2021
- 2021-05-12 CN CN202180047016.6A patent/CN115956120A/zh active Pending
- 2021-05-12 EP EP21803427.0A patent/EP4150091A4/en active Pending
- 2021-05-12 US US17/318,846 patent/US20210388348A1/en active Pending
- 2021-05-12 CA CA3177463A patent/CA3177463A1/en active Pending
- 2021-05-12 AU AU2021271004A patent/AU2021271004A1/en active Pending
- 2021-05-12 JP JP2022568828A patent/JP2023526057A/ja active Pending
- 2021-05-12 WO PCT/US2021/032038 patent/WO2021231606A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7209682B2 (ja) | 多標的単一体コンジュゲート | |
| Rayburn et al. | Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? | |
| JP7478210B2 (ja) | 修飾オリゴヌクレオチド及び使用方法 | |
| US7723512B2 (en) | Oligonucleotides comprising a non-phosphate backbone linkage | |
| EP3523437A1 (en) | Oligonucleotide compositions and methods thereof | |
| CN105705638B (zh) | 改善的具有高效能的纳米颗粒型寡核苷酸结构及其制备方法 | |
| JP2021533804A5 (https=) | ||
| JP2020533009A (ja) | ＧａｌＮＡｃ誘導体 | |
| JP2021529173A5 (https=) | ||
| CA3092148A1 (en) | Modified guide rnas for crispr genome editing | |
| JP2023537798A5 (https=) | ||
| JP2022551269A (ja) | 最小フッ素含有量を用いた低分子干渉ｒｎａの化学修飾 | |
| JP2023526057A5 (https=) | ||
| CN104011209A (zh) | 病毒基因表达的抑制 | |
| JP2020050670A (ja) | オリゴヌクレオチド組成物及びその作製方法 | |
| CN110997918A (zh) | 单链寡核苷酸 | |
| TW201706284A (zh) | 使用多價陽離子鹽組合物之聚核苷酸製備方法 | |
| Brzezinska et al. | Synthesis of 2′-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus | |
| JP7128517B2 (ja) | 副作用を減じたアンチセンス核酸 | |
| CN121816417A (zh) | 双链寡核苷酸药剂和其用途 | |
| JP2025513757A5 (https=) | ||
| US20250250570A1 (en) | Translation enhancing nucleic acid compounds: aso coupled translation – upregulation 1 (act-up1) and uses thereof | |
| WO2025223315A1 (zh) | 一种用于肝脏特异性递送的多靶标双链rna偶联物及药物组合物 | |
| WO2025165891A1 (en) | Translation enhancing nucleic acid compounds: aso coupled translation - upregulation 1 (act-up1) and uses thereof | |
| WO2024006672A2 (en) | Modified guide rnas for crispr genome editing |